87 related articles for article (PubMed ID: 29785036)
1. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
Fu Q; Yang F; Xiang T; Huai G; Yang X; Wei L; Yang H; Deng S
Sci Rep; 2018 May; 8(1):7933. PubMed ID: 29785036
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
He D; Zhang X; Tu J
Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
Lin YR; Yang WJ; Yang GW
Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
[TBL] [Abstract][Full Text] [Related]
4. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
Pei W; Jiang M; Liu H; Song J; Hu J
Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
[TBL] [Abstract][Full Text] [Related]
5. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma.
Chen C; Wang C; Liu W; Chen J; Chen L; Luo X; Wu J
Cancer Biomark; 2024; 39(4):361-370. PubMed ID: 38160346
[TBL] [Abstract][Full Text] [Related]
7. Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
Ji Z; Zhang C; Yuan J; He Q; Zhang X; Yang D; Xu N; Chu J
PLoS One; 2024; 19(4):e0298775. PubMed ID: 38662757
[TBL] [Abstract][Full Text] [Related]
8. Identification of PPAR-related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking.
Wang Y; Li S; Liu Z; Li X; Yu Y; Liu H
J Cell Mol Med; 2024 Apr; 28(8):e18304. PubMed ID: 38652093
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis.
Zong RQ; Zhang HY; Li XY; Li YR; Chen Y
Genet Res (Camb); 2022; 2022():7067743. PubMed ID: 36262249
[TBL] [Abstract][Full Text] [Related]
11. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers.
Zhou J; Cui X; Xiao F; Cai G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546390
[TBL] [Abstract][Full Text] [Related]
12. Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma.
Feng J; Wei X; Liu Y; Zhang Y; Li G; Xu Y; Zhou P; Zhang J; Han X; Zhang C; Zhang Y; Wang G
Aging (Albany NY); 2023 Nov; 15(22):13010-13040. PubMed ID: 37980167
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma.
Samara M; Vlachostergios PJ; Thodou E; Zachos I; Mitrakas L; Evmorfopoulos K; Tzortzis V; Giakountis A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003433
[TBL] [Abstract][Full Text] [Related]
14. Exploring the diagnostic value, prognostic value, and biological functions of NPC gene family members in hepatocellular carcinoma based on a multi-omics analysis.
Chen K; Zhang X; Peng H; Huang F; Sun G; Xu Q; Liao L; Xing Z; Zhong Y; Fang Z; Liao M; Luo S; Chen W; Dong M
Funct Integr Genomics; 2023 Aug; 23(3):264. PubMed ID: 37541978
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata.
Bae AN; Kim J; Park JH; Lee JH; Choi E
Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893500
[No Abstract] [Full Text] [Related]
16. Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma.
Tang Q; Wang S; Li H; Liu J; Hu X; Zhao D; Di M
Aging (Albany NY); 2024 Jan; 16(1):593-616. PubMed ID: 38206300
[TBL] [Abstract][Full Text] [Related]
17. Identification of NAA40 as a Potential Prognostic Marker for Aggressive Liver Cancer Subtypes.
Koufaris C; Kirmizis A
Front Oncol; 2021; 11():691950. PubMed ID: 34150665
[TBL] [Abstract][Full Text] [Related]
18. Anoikis-related signature in liver hepatocellular carcinoma defines the YBX1/SPP1 axis by machine learning strategies and valid experiments.
Ma Y; She X; Zhao J; Liu S; Li C; Wang Q
J Gene Med; 2023 Oct; 25(10):e3516. PubMed ID: 37118998
[TBL] [Abstract][Full Text] [Related]
19. miRNA profiling of cancer.
Di Leva G; Croce CM
Curr Opin Genet Dev; 2013 Feb; 23(1):3-11. PubMed ID: 23465882
[TBL] [Abstract][Full Text] [Related]
20. Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses.
Su C; Yang JC; Rong Z; Li F; Luo LX; Liu G; Cheng CY; Zhao MG; Yang L
Heliyon; 2023 Sep; 9(9):e19233. PubMed ID: 37674842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
